- Home
- AADI vs RAND Comparison
AADI vs RAND Comparison
Compare AADI & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AADI
- RAND
- Stock Information
- Founded
- AADI 2011
- RAND 1969
- Country
- AADI United States
- RAND United States
- Employees
- AADI 70
- RAND N/A
- Industry
- AADI Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- AADI Health Care
- RAND Finance
- Exchange
- AADI Nasdaq
- RAND Nasdaq
- Market Cap
- AADI 51.7M
- RAND 47.5M
- IPO Year
- AADI N/A
- RAND N/A
- Fundamental
- Price
- AADI $2.10
- RAND $16.78
- Analyst Decision
- AADI Hold
- RAND
- Analyst Count
- AADI 3
- RAND 0
- Target Price
- AADI $1.75
- RAND N/A
- AVG Volume (30 Days)
- AADI 102.0K
- RAND 1.3K
- Earning Date
- AADI 11-06-2024
- RAND 11-04-2024
- Dividend Yield
- AADI N/A
- RAND 6.92%
- EPS Growth
- AADI N/A
- RAND 72.67
- EPS
- AADI N/A
- RAND 4.19
- Revenue
- AADI $23,817,000.00
- RAND $7,874,601.00
- Revenue This Year
- AADI $4.79
- RAND N/A
- Revenue Next Year
- AADI $10.72
- RAND N/A
- P/E Ratio
- AADI N/A
- RAND $3.91
- Revenue Growth
- AADI 10.57
- RAND 13.24
- 52 Week Low
- AADI $1.21
- RAND $12.50
- 52 Week High
- AADI $5.70
- RAND $19.60
- Technical
- Relative Strength Index (RSI)
- AADI 63.80
- RAND 48.97
- Support Level
- AADI $1.90
- RAND $16.39
- Resistance Level
- AADI $2.17
- RAND $17.26
- Average True Range (ATR)
- AADI 0.09
- RAND 0.28
- MACD
- AADI 0.00
- RAND 0.01
- Stochastic Oscillator
- AADI 70.49
- RAND 44.25
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.